These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24030071)

  • 1. Sinus dysfunction after stent implantation in the right coronary artery immediately recovered after reflow in the sinus node artery.
    Haraki T; Hirase H; Hoda S; Hashimoto M; Higashi M
    Cardiovasc Interv Ther; 2014 Apr; 29(2):173-6. PubMed ID: 24030071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinus arrest caused by occlusion of the sinus node artery during percutaneous coronary intervention for lesions of the proximal right coronary artery.
    Kotoku M; Tamura A; Naono S; Kadota J
    Heart Vessels; 2007 Nov; 22(6):389-92. PubMed ID: 18043996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-standing sinus arrest due to the occlusion of sinus node artery during percutaneous coronary intervention: Clinical implications and management.
    Nakou ES; Simantirakis EN; Kallergis EM; Skalidis EI; Vardas PE
    Int J Cardiol; 2016 Jan; 203():432-3. PubMed ID: 26547050
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study.
    Kubo T; Imanishi T; Kitabata H; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Takarada S; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged sinus arrest due to the obstruction of a sinus node branch after percutaneous coronary intervention of the right coronary artery.
    Shimizu R; Aoyama R; Ishikawa J; Harada K
    J Cardiol Cases; 2022 May; 25(5):319-322. PubMed ID: 35582079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound attenuated coronary plaque as a risk factor for slow flow or no-reflow during percutaneous coronary intervention: a case report.
    Furuichi S; Itoh A; Ishibashi-Ueda H; Noguchi T; Miyawaki M; Nomura K; Arita Y; Otsuka M; Shindo T
    J Cardiol; 2007 Apr; 49(4):193-7. PubMed ID: 17460880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stent fracture and restenosis after zotarolimus-eluting stent implantation.
    Park JS; Cho IH; Kim YJ
    Int J Cardiol; 2011 Mar; 147(2):e29-31. PubMed ID: 19203806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does underlying plaque morphology play a role in vessel healing after drug-eluting stent implantation?
    Finn AV; Nakazawa G; Ladich E; Kolodgie FD; Virmani R
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):485-8. PubMed ID: 19356471
    [No Abstract]   [Full Text] [Related]  

  • 9. Covered stent for the treatment of coronary aneurysm after sirolimus-eluting stent implantation in a patient with Takayasu's arteritis.
    Fefer P; Hogg D; Radhakrishnan S
    J Invasive Cardiol; 2009 Nov; 21(11):611-2. PubMed ID: 19901419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angio quiz. Intra-arterial hematoma after percutaneous coronary intervention of Shepard's Crook right coronary artery.
    Mishra S
    Indian Heart J; 2009; 61(2):209-10. PubMed ID: 20039510
    [No Abstract]   [Full Text] [Related]  

  • 11. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sinus arrest following right coronary artery stent implantation.
    Deeprasertkul P; Thakur RK
    Int Arch Med; 2012 Mar; 5(1):11. PubMed ID: 22433667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary angioscopic findings 9 months after everolimus-eluting stent implantation compared with sirolimus-eluting stents.
    Dai K; Ishihara M; Inoue I; Kawagoe T; Shimatani Y; Miura F; Nakama Y; Otani T; Ooi K; Ikenaga H; Nakamura M; Miki T; Kishimoto S; Sumimoto Y
    J Cardiol; 2013 Jan; 61(1):22-30. PubMed ID: 23078862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coronary artery bypass grafting for simultaneous subacute stent thrombosis after sirolimus-eluting stent implantation].
    Matsumoto M; Suehiro K; Kubo Y; Onoue G; Komatsubara I; Seito T; Morimoto N; Shiraishi K; Kasai S; Hagioka S; Naito H; Nagae M
    Kyobu Geka; 2008 May; 61(5):355-8. PubMed ID: 18464477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In-stent-stenosis of a bare-metal stent 11 years after its implantation].
    Skarlos AC; Zahn R; Zeymer U
    Dtsch Med Wochenschr; 2010 May; 135(21):1067-70. PubMed ID: 20486056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iatrogenic left internal mammary artery-coronary vein anastomosis treated with covered stent deployment via retrograde percutaneous coronary sinus approach.
    Sheiban I; Moretti C; Colangelo S
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):704-7. PubMed ID: 17039511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
    JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions).
    Garg S; Serruys P; Onuma Y; Dorange C; Veldhof S; Miquel-Hébert K; Sudhir K; Boland J; Huber K; Garcia E; te Riele JA;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1190-8. PubMed ID: 20129545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes with 6 months dual antiplatelet therapy after implantation of biolimus-A9 drug eluting coronary stents.
    Cockburn J; Pareek N; Poliacikova P; Saraf S; Williams R; Dhillon G; Robinson D; Gerber R; Hatrick R; Blows L; de Belder A; Hildick-Smith D
    Int J Cardiol; 2014 Mar; 172(1):185-9. PubMed ID: 24462139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.